HLA-DR-Triggered Inhibition of Hemopoiesis Involves Fas/Fas Ligand Interactions and Is Prevented by c-kit Ligand

Journal of Immunology

Volumn 159, Issue 7, 1997, Pages 3211-3219

  Lee, Jong Wook ^a,d   Gersuk, Geoffrey M ^a   Kiener, Peter A ^b   Beckham, Cassandra ^a   Ledbetter, Jeffrey A ^b   Deeg, H Joachim ^a,c  

^a USA   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; GROWTH INHIBITOR; HLA DR ANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; LIGAND; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; STEM CELL FACTOR;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; BONE MARROW CELL; CELL CULTURE; DRUG EFFECT; GENETICS; HEMATOPOIESIS; HUMAN; IMMUNOLOGY; PHYSIOLOGY; TIME;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD34; ANTIGENS, CD95; APOPTOSIS; BONE MARROW CELLS; CELLS, CULTURED; FAS LIGAND PROTEIN; GROWTH INHIBITORS; HEMATOPOIESIS; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; LIGANDS; MEMBRANE GLYCOPROTEINS; RECOMBINANT FUSION PROTEINS; STEM CELL FACTOR; TIME FACTORS;

EID: 0031253717     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Young, N. S., and B. P. Alter. 1994. Aplastic Anemia: Acquired and Inherited. W. B. Saunders Co., Philadelphia.
2. Viale, M., A. Merli, and A. Bacigalupo. 1991. Analysis at the clonal level of T-cell phenotype and functions in severe aplastic anemia patients. Blood 78:1268.
3. + cells of patients with aplastic anaemia. Br. J. Haematol. 91:245.
4. Nakao, S., M. Yamaguchi, S. Shiobara, T. Yokoi, T. Miyawaki, T. Taniguchi, and T. Matsuda. 1992. Interferon-gamma gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia. Blood 79:2532.
5. + human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183.
6. Nagafuji, K., T. Shibuya, M. Harada, S. Mizuno, K. Takenaka, T. Miyamoto, T. Okamura, H. Gondo, and Y. Niho. 1995. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86:883.
7. Hatake, K., H. Tomizuka, M. Ikeda, J. Tsunoda, Y. Hoshino, T. Ohtsuki, T. Kasahara, S. Yonehara, and Y. Miura. 1994. The presence of apoptosis in refractory anemia of myelodysplasia. In Molecular Biology of Haematopoiesis, Vol. 3. N. Abraham, R. K. Shadduck, A. S. Levine, and F. Takaku, eds. Intercept Ltd., Andover, U.K., p. 127.
8. Philpott, N. J., J. Scopes, J. C. W. Marsh, E. C. Gordon-Smith, and F. M. Gibson. 1995. Increased apoptosis in aplastic anemia bone marrow progenitor cells: possible pathophysiologic significance. Exp. Hematol. 23:1642.
9. Singer, G. G., A. C. Carrera, A. Marshak-Rothstein, C. Martinez, and A. K. Abbas. 1994. Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model. Curr. Opin. Immunol. 6:913.
10. Rose, L. M., D. S. Latchman, and D. A. Isenberg, 1994. Bcl-2 and Fas, molecules which influence apoptosis: a possible role in systemic lupus erythematosus? Autoimmunity 17:271.
11. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233.
12. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
13. Suda, T., and S. Nagata. 1994. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179:873.
14. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747.
15. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwin, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71.
16. Cleveland, J. L., and J. N. Ihle. 1995. Contenders in FasL/TNF death signaling. Cell 81:479.
17. Eischen, C. M., C. J. Dick, and P. J. Leibson. 1994. Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J. Immunol. 153:1947.
18. Sato, T., S. Irie, S. Kitada, and J. C. Reed. 1995. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268:411.
19. Krammer, P. H., J. Dhein, H. Walczak, I. Behrmann, S. Mariani, B. Matiba, M. Fath, P. T. Daniel, E. Knipping, M. O. Westendorp, K. Stricker, C. Bäumler, S. Hellbardt, M. Germer, M. E. Peter, and K.-M. Debatin. 1994. The role of APO-1-mediated apoptosis in the immune system. Immunol. Rev. 142:175.
20. Dhein, J., H. Walczak, C. Baumler, K. M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature 373:438.
21. + T cells. Nature 376:181.
22. Greinix, H. T., W. C. Ladiges, T. C. Graham, S. Maslan, R. F. Raff, B. M. Sandmaier, F. R. Appelbaum, F. G. Schuening, H. J. Deeg, and R. Storb. 1991. Late failure of autologous marrow grafts in lethally irradiated dogs given anti-class-II monoclonal antibody. Blood 78:2131.
23. Deeg, H. J., C. Beckham, R. Huss, D. Myerson, H. Greinix, F. R. Appelbaum, T. Graham, F. Schuening, and R. Storb. 1994. Rescue from anti-MHC class II antibody-mediated marrow graft failure by c-kit ligand. Blood 83:2352.
24. Hong, D.-S., C. Beckham, R. Huss, J. W. Lee, D. Hockenbery, J. A. Ledbetter, and H. J. Deeg. 1995. Major histocompatibility complex class II-mediated inhibition of hematopoiesis in long-term marrow cultures involves apoptosis and is prevented by c-kit ligand. Blood 86:3341.
25. Williams, D. E., J. Eisenman, A. Baird, C. Rauch, K. Van Ness, C. J. March, L. S. Park, U. Martin, D. Y. Mochizuki, H. S. Boswell, G. S. Burgess, D. Cosman, and S. D. Lyman. 1990. Identification of a ligand for the c-kit protooncogene. Cell 63:167.
26. Yamaguchi, Y., Y. Gunji, M. Nakamura, K. Hayakawa, M. Maeda, H. Osawa, K. Nagayoshi, T. Kasahara, and T. Suda. 1993. Expression of c-kit mRNA and protein during the differentiation of human hematopoietic progenitor cells. Exp. Hematol. 21:1233.
27. Broudy, V. C., D. A. Morgan, N. Lin, K. M. Zsebo, F. W. Jacobsen, and T. Papayannopoulou. 1993. Stem cell factor influences the proliferation and erythroid differentiation of the MB-02 human erythroleukemia cell line by binding to a high-affinity c-kit receptor. Blood 82:436.
28. Williams, G. T., C. A. Smith, E. Spooncer, T. M. Dexter, and D. R. Taylor. 1990. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76.
29. Williams, N., I. Benoncello, H. Kavnoudias, K. Zsebo, and I. McNiece. 1992. Recombinant rat stem cell factor stimulates the amplification and differentiation of fractionated mouse stem cell populations. Blood 79:58.
30. Jacobsen, F. W., C. M. Dubois, L. S. Rusten, O. P. Veiby, and S. E. W. Jacobsen. 1995. Inhibition of stem cell factor-induced proliferation of primitive murine hematopoietic progenitor cells signaled through the 75-kilodalton tumor necrosis factor receptor. J. Immunol. 154:3732.
31. Yamaguchi, M., G. Gersuk, S. Nadler, and H. J. Deeg. 1996. HLA-DR mediated apoptosis and inhibition of hematopoiesis involves upregulation of tumor necrosis factor alpha. Exp. Hematol. 24:1100 (Abstr.).
32. Greinix, H. T., R. Storb, and S. H. Bartelmez. 1992. Specific growth inhibition of primitive hematopoietic progenitor cells mediated through monoclonal antibody binding to major histocompatibility class II molecules. Blood 80:1950.
33. Srour, E. F., J. E. Brandt, R. A. Briddell, S. Grigsby, T. Leemhuis, and R. Hoffman. 1993. Long-term generation and expansion of human primitive hematopoietic progenitor cells in vitro. Blood 81:661.
34. Dexter, T. M., T. D. Allen, and L. G. Lajtha. 1977. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J. Cell. Physiol. 91:335.
35. Accolla, R. S., D. Birnbaum, and M. Pierres. 1983. The importance of cross-reactions between species: mouse allo-anti-Ia monoclonal antibodies as a powerful tool to define human Ia subsets. Hum. Immunol. 8:75.
36. Broudy, V. C., N. Lin, K. M. Zsebo, N. C. Birkett, K. A. Smith, I. D. Bernstein, and T. Papayannopoulou. 1992. Isolation and characterization of a monoclonal antibody that recognizes the human c-kit receptor. Blood 79:338.
37. Liles, W. C., P. A. Kiener, J. A. Ledbetter, A. Aruffo, and S. J. Klebanoff. 1996. Differential expression of Fas (CD95) and Fas-ligand on normal human phagocytes: implications for regulation of apoptosis in neutrophils. J. Exp. Med. 184:429.
38. Berenson, R. J., W. I. Bensinger, and D. Kalamasz. 1986. Positive selection of viable cell populations using avidin-biotin immunoadsorption. J. Immunol. Methods 91:11.
39. Lee, J. W., C. Beckham, G. Gersuk, P. Kiener, and H. J. Deeg. 1996. HLA-DR-initiated inhibition of hematopoiesis involves apoptosis via a Fas/Fas-ligand pathway. Exp. Hematol. 24:1084.
40. lo human marrow cells after in vitro cytokine exposure. Blood 85:1480.
41. Sutherland, H. J., P. M. Lansdorp, D. H. Henkelman, A. C. Eaves, and C. J. Eaves. 1990. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc. Natl. Acad. Sci. USA 87:3584.
42. Nicoletti, I., G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139:271.
43. Blechman, J. M., S. Lev, D. Givol, and Y. Yarden. 1993. Structure-function analyses of the kit receptor for the steel factor. Stem Cells 11(Suppl. 2):12.
44. Sgonc, R., G. Boeck, H. Dietrich, J. Gruber, H. Recheis, and G. Wick. 1994. Simultaneous determination of cell surface antigens and apoptosis. Trends Genet. 10:41.
45. Gorczyca, W., K. Bigman, A. Mittelman, T. Ahmed, J. Gong, M. R. Melamed, and Z. Darzynkiewicz. 1993. Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 7:659.
46. Yoshimo, T., L. Cao, R. Nishiuchi, Y. Matsuo, I. Yamdori, E. Kondo, N. Teramoto, K. Hayashi, K. Takahashi, N. Kamikawaji, and T. Akagi. 1995. Ligation of HLA class II molecules promotes sensitivity to CD95 (Fas antigen, APO-1)-mediated apoptosis. Eur. J. Immunol. 25:2190.
47. Reith, W., V. Steimle, and B. Mach. 1995. Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes, Immunol. Today 16:539.
48. Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10:13.
49. Sprent, J., and S. R. Webb. 1995. Intrathymic and extrathymic clonal deletion of T cells. Curr. Opin. Immunol. 7:196.
50. Chatila, T., and R. S. Geha. 1993. Signal transduction by microbial superantigens via MHC class II molecules. Immunol. Rev. 131:43.
51. Odum, N., P. J. Martin, G. L. Schieven, J. A. Hansen, and J. A. Ledbetter. 1991. Signal transduction by HLA class II antigens expressed on activated T cells. Eur. J. Immunol. 21:123.
52. Meyers, J. D., J. C. Wade, and L. M. Day. 1982. Effect of indomethacin on the in vitro lymphocyte transformation response to herpes simplex virus antigen and phytohemagglutinin after marrow transplant. J. Infect. Dis. 146:289.
53. Hauschildt, S., W. G. Bessler, and P. Scheipers. 1993. Engagement of major histocompatibility complex class II molecules leads to nitrite production in bone marrow-derived macrophages. Eur. J. Immunol. 23:2988.
54. Moore, M. A. S., H. E. Broxmeyer, A. P. C. Sheridan, P. A. Meyers, N. Jacobsen, and R. J. Winchester. 1980. Continuous human bone marrow culture: Ia antigen characterization of probable pluripotentiat stem cells. Blood 55:682.
55. - bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis. Blood Cells 17:287.
56. Verfaillie, C. M., W. J. Miller, K. Boylan, and P. B. McGlave. 1992. Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood 79:1003.
57. Falkenburg, J. H. F., J. Jansen, N. van der Vaart-Duinkerken, W. F. J. Veenhof, J. Blotkamp, H. M. Goselink, J. Parlevliet, and J. J. van Rood. 1984. Polymorphic and monomorphic HLA-DR determinants on human hematopoietic progenitor cells. Blood 53:1125.
58. Keating, A., J. Powell, M. Takahashi, and J. W. Singer. 1984. The generation of human long-term marrow cultures from marrow depleted of Ia (HLA-DR) positive cells. Blood 64:1159.
59. + hematopoietic cells. Blood 88:2619.
60. Deeg, H. J., J. C. Wulff, S. DeRose, G. E. Sale, M. Braun, M. A. Brown, S. C. Springmeyer, P. J. Martin, and R. Storb. 1982. Unusual distribution of Ia-like antigens on canine lymphocytes. Immunogenetics 16:445.
61. Andre, P., J. C. Cambier, T. K. Wade, T. Raetz, and W. F. Wade. 1994. Distinct structural compartmentalization of the signal transducing functions of major histocompatibility complex class II (Ia) molecules. J. Exp. Med. 179:763.
62. Scholl, P. R., and R. S. Geha. 1994. MHC class II signaling in B-cell activation. Immunol. Today 15:418.
63. Muzio, M., A. M. Chinnaiyan, F. C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, M. Mann, P. H. Krammer, M. E. Peter, and V. M. Dixit. 1996. FLICE, a novel FADD-homologous ICE/ CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817.
64. Boldin, M. P., T. M. Goncharov, Y. V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT1/FADD-inleracting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 85:803.
65. Gersuk, G. M., J. W. Lee, C. A. Beckham, J. Anderson, and H. J. Deeg. 1996. Fas (CD95) receptor and fas-ligand expression in bone marrow cells from patients with myelodysplastic syndrome. Blood 88:1122 (Lett.).
66. Raza, A., S. Gezer, S. Mundle, X. Z. Gao, S. Alvi, R. Borok, S. Rifkin, A. Iftikhar, V. Shetty, A. Parcharidou, J. Loew, B. Marcus, Z. Khan, C. Chaney, J. Showel, S. Gregory, and H. Preisler. 1995. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 86:268.
67. Bogdanovic, A. D., G. M. Jankovic, M. D. Colovic, D. P. Trpinac, and V. Z. Bumbasirevic. 1996. Apoptosis in bone marrow or myelodysplastic syndrome patients. Blood 87:3064.
68. Renno, T., M. Hahne, J. Tschopp, and H. R. MacDonald. 1996. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J. Exp. Med. 183:431.